Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model

Rohit Oemrawsingh; Martijn Akkerhuis; Laura Vark; Ken Redekop; Goran Rudez; WJ Remme; ME Bertrand; KM Fox; R Ferrari; Jan Danser; Moniek de Maat; Maarten Simoons; Jasper Brugts; Eric Boersma

doi:10.1161/JAHA.115.002688

Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model

Rohit Oemrawsingh, Martijn Akkerhuis, Laura Vark, Ken Redekop, Goran Rudez, WJ Remme, ME Bertrand, KM Fox, R Ferrari, Jan Danser, Moniek de Maat, Maarten Simoons, Jasper Brugts, Eric Boersma

Research output: Contribution to journal › Article › Academic › peer-review

19 Citations (Scopus)

9 Downloads (Pure)

Original language	English
Pages (from-to)	e002688
Number of pages	12
Journal	Journal of the American Heart Association
Volume	5
Issue number	3
DOIs	https://doi.org/10.1161/JAHA.115.002688
Publication status	Published - 2016

Research programs

EMC NIHES-05-63-02 Quality
EMC COEUR-09
EMC COEUR-09-39-02

Access to Document

10.1161/JAHA.115.002688

REPUB_94950.pdfFinal published version, 1.02 MB

http://hdl.handle.net/1765/94950

Cite this

Oemrawsingh, R., Akkerhuis, M., Vark, L., Redekop, K., Rudez, G., Remme, WJ., Bertrand, ME., Fox, KM., Ferrari, R., Danser, J., de Maat, M., Simoons, M., Brugts, J., & Boersma, E. (2016). Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model. Journal of the American Heart Association, 5(3), e002688. https://doi.org/10.1161/JAHA.115.002688

@article{181ae9b13ef94dc69d56d7a85da02209,

title = "Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model",

author = "Rohit Oemrawsingh and Martijn Akkerhuis and Laura Vark and Ken Redekop and Goran Rudez and WJ Remme and ME Bertrand and KM Fox and R Ferrari and Jan Danser and {de Maat}, Moniek and Maarten Simoons and Jasper Brugts and Eric Boersma",

year = "2016",

doi = "10.1161/JAHA.115.002688",

language = "English",

volume = "5",

pages = "e002688",

journal = "Journal of the American Heart Association",

issn = "0039-2499",

publisher = "John Wiley & Sons Inc.",

number = "3",

}

Oemrawsingh, R, Akkerhuis, M, Vark, L, Redekop, K, Rudez, G, Remme, WJ, Bertrand, ME, Fox, KM, Ferrari, R, Danser, J , de Maat, M, Simoons, M, Brugts, J & Boersma, E 2016, 'Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model', Journal of the American Heart Association, vol. 5, no. 3, pp. e002688. https://doi.org/10.1161/JAHA.115.002688

Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model. / Oemrawsingh, Rohit; Akkerhuis, Martijn; Vark, Laura et al.
In: Journal of the American Heart Association, Vol. 5, No. 3, 2016, p. e002688.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model

AU - Oemrawsingh, Rohit

AU - Akkerhuis, Martijn

AU - Vark, Laura

AU - Redekop, Ken

AU - Rudez, Goran

AU - Remme, WJ

AU - Bertrand, ME

AU - Fox, KM

AU - Ferrari, R

AU - Danser, Jan

AU - de Maat, Moniek

AU - Simoons, Maarten

AU - Brugts, Jasper

AU - Boersma, Eric

PY - 2016

Y1 - 2016

U2 - 10.1161/JAHA.115.002688

DO - 10.1161/JAHA.115.002688

M3 - Article

C2 - 27021566

SN - 0039-2499

VL - 5

SP - e002688

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

IS - 3

ER -